Comparison of three analgesic treatment protocols for pain management during extracorporeal shock wave lithotripsy
Urol Int · 2009 · Vol. 82 · Issue 3 · 276-279
Academy Summary
Comparison of three analgesic treatment protocols for pain management during extracorporeal shock wave lithotripsy examined a clinically important component of shock wave lithotripsy, with particular relevance to SWL Pain Management.
The investigators used a Randomized Comparative Trial in adults undergoing swl. This design strengthens comparison between the treatment strategies studied, although the conclusions still remain tied to the lithotripter, protocol and eligibility criteria used.
A comparative study reported stronger pain control with diclofenac than EMLA alone, while combining the two did not clearly outperform systemic NSAID treatment.
Pain control during SWL is part of treatment quality, not merely patient comfort.
Analgesia studies should be interpreted through both comfort and technical performance because pain-related movement can reduce effective stone targeting. A comfortable patient is more likely to remain still, breathe predictably and maintain stable stone alignment throughout treatment.
Published in 2009, the study predates several contemporary refinements in SWL technique. The clinical principle remains relevant, but absolute rates and machine settings should be interpreted in their technological era.
For the Lithotripsy Academy database, the paper is most useful when interpreted as part of the complete treatment pathway rather than as an isolated numerical rule. Patient selection determines the opportunity for success, while targeting, coupling, shock-wave rate, energy strategy and operator technique determine how effectively that opportunity is converted into fragmentation and clearance.
Continue Learning
Explore related clinical guidance and structured education.
Comments & Discussion0 comments
Discuss the publication's evidence, limitations and practical relevance. Please do not include identifiable patient information or individual medical advice.
No comments yet. Start the discussion.
Please log in to join the discussion.
